Table 3.
Characteristics of anaphylaxis cases (27 cases).
| Patient Number | Sex/Age | Concentration during Anaphylaxis | Volume during Anaphylaxis | No. Treatments until Anaphylaxis | Administration | Anaphylaxis Grade c | Treatment Result |
|---|---|---|---|---|---|---|---|
| P1 | Unknown | Unknown | Unknown | 4 | Unknown | III | Recovered |
| P2–5 | 4 patients /(Unknown) |
Unknown | Unknown | Unknown | Unknown | Unknown | Unknown |
| P6–16 a | 11 patients /(40.9 ± 12 a) |
Unknown | 1.6 cc ± 0.5 | 10.9 ± 6.8 | Unknown | Unknown | Recovered |
| P17 b | Unknown | Unknown | 0.4 cc | 24 | Intradermal | Unknown | Unknown |
| P18 | Unknown | 10,000:1 | Unknown | Unknown | Unknown | IV | Recovered |
| P19 | F/36 | Unknown | 2 cc | 6 | Intradermal | Unknown | Recovered |
| P20 | F/61 | 10,000:1 | 0.5 cc | 1 | Unknown | III | Recovered |
| P21 | F/65 | 10,000:1 | 0.1 cc | Test | Unknown | III | Recovered |
| P22 | F/77 | 10,000:1 | 1 cc | Unknown | Unknown | IV | Recovered |
| P23 | M/70 | 10,000:1 | 2 cc | 6 | Intramuscular | III | Recovered |
| P24 | F/59 | 10,000:1 | 2 cc | 2 | Intramuscular | IV | Recovered |
| P25 | F/62 | 10,000:1 | 2 cc | 13 | Intramuscular | III | Recovered |
| P26 | F/60 | 10,000:1 | 2 cc | 6 | Intramuscular | III | Recovered |
| P27 | F/42 | 10,000:1 | 2 cc | 22 | Intramuscular | IV | Recovered |
a All items are the mean values of 11 patients, b volume and treatment session are estimated from data presented, c Mueller grade.